News
From boiled veggies to fresh coconut, here’s what older adults with diabetes should eat every day for breakfast, lunch, ...
Researchers at UT Arlington have discovered a key enzyme, IDO1, that when blocked, helps immune cells regain their ability to properly process cholesterol—something that breaks down during ...
A UCSF analysis has found that the newer generation of much more effective diabetes medications are reaching only a fraction ...
Some research shows that intentional fasting may have positive effects on blood sugar, but skipping meals usually isn’t ...
A Milwaukee woman shares her experience of becoming a mother at 42, highlighting the increasing number of women over 40 ...
Both semaglutide and tirzepatide for type 2 diabetes and weight loss are GLP-1 agonists, meaning they mimic the hormone. Ozempic for blood sugar control and Wegovy for weight loss both use different ...
With specific strategies, people with diabetes can enjoy the buffet and keep blood sugar stable. If picking one thing off the ...
Negotiations are ongoing in New York to agree the latest UN political declaration on non-communicable diseases (NCDs) and ...
We have witnessed weight loss of 13–15% with the glucagon-like peptide-1 (GLP-1) receptor agonist semaglutide and up to 18–23% with the dual GLP-1/glucose-dependent insulinotropic polypeptide (GIP) ...
Diabetics are more likely to develop Alzheimer’s than the general public. Could a popular diabetes and weight-loss drug also stave off dementia?
Alumni Nicole Friedland (Merrill ’89, community studies) and Brett King (Crown ’92, chemistry) both spoke at the National ...
Type 2 diabetes is more aggressive in young people, harder to manage and more likely to lead to a premature death.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results